Following pressure from the U.S. Food and Drug Administration, 23andMe—which retails DNA tests for mainstream consumers—has announced that it will continue its genetic testing service, but will no longer offer health-related interpretations of the results for consumers. The company emphasized both on its site and in its press release that the service might resume in the future if the FDA permits it.
23andMe said it will will continue to offer “both ancestry-related genetic tests and raw genetic data, without 23andMe’s interpretation.”
Image courtesy of Flickr user Derek Purdy
